Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations
Life Medicine · 08.10.2025 · 4 (5)
DOI: 10.1093/lifemedi/lnaf030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Medicine, online erschienen am 25.11.2025. Verfasst von Ju Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoono…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Activated phosphoinositide 3-kinase delta syndrome (APDS) is a primary immunodeficiency characterized by hyperactivated lymphocytes and recurrent infections. This study presents a 2.5-year-old patient with a novel PIK3CD gene mutation (c.1309C>T; p. R437C) derived from his mother. We explored the immunological consequences of this mutation in both the patient and his mother, revealing defects in T cell differentiation, B cell maturation, and mitochondrial function. Notably, we found that the elevated CD38 expression on B cells is a key factor driving B cell senescence, mitochondrial dysfunction, and increased transitional B cell proportion, contributing to the observed immunodeficiency, such as diminished serum antibodies. Further investigations of the PI3K/AKT/mTOR pathway highlight a preferential activation of mTORC2 over mTORC1. We also demonstrate that the transcription factor FOXO1, a downstream molecule of PI3K/AKT signaling, regulates CD38 expression by binding to the promotor of the CD38 gene, linking this pathway to B cell dysfunction. This novel mutation expands the spectrum of PIK3CD mutations associated with APDS and provides new insights into the molecular mechanisms underlying B-cell senescence and other immune dysregulation. Moreover, targeting the AKT–FOXO1 axis could offer therapeutic potential to reverse B-cell dysfunction and improve immune responses in patients with PIK3CD mutations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology…
- Department of Immunology, School of Medicine, Yangtze University, Jingzhou 434100, China.
- Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zitieren
APA
Liu, J., Bai, Y., Tang, J., Jin, P., Huang, Y., Yang, L., Wang, Y., Wu, X., & Liu, C. (2025). Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations. Life Medicine, 4(5). https://doi.org/10.1093/lifemedi/lnaf030
Vancouver
Liu J, Bai Y, Tang J, Jin P, Huang Y, Yang L, et al. Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations. Life Medicine. 2025;4(5). doi:10.1093/lifemedi/lnaf030
BibTeX
@article{Liu2025,
author = {Liu, Ju and Bai, Yuxin and Tang, Jianing and Jin, Peiyao and Huang, Yanmei and Yang, Lu and Wang, Ying and Wu, Xiaochuan and Liu, Chaohong},
title = {Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations},
journal = {Life Medicine},
year = {2025},
volume = {4},
number = {5},
doi = {10.1093/lifemedi/lnaf030}
}
EUVIMED